• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对单一机构中Knosp 0-2级无功能垂体大腺瘤的显微手术与内镜经蝶窦手术同期系列病例进行回顾性分析。

Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.

作者信息

Dallapiazza Robert, Bond Aaron E, Grober Yuval, Louis Robert G, Payne Spencer C, Oldfield Edward H, Jane John A

机构信息

Departments of Neurosurgery and.

出版信息

J Neurosurg. 2014 Sep;121(3):511-7. doi: 10.3171/2014.6.JNS131321. Epub 2014 Jul 4.

DOI:10.3171/2014.6.JNS131321
PMID:24995783
Abstract

OBJECT

The object of this study was to compare surgical outcomes and complications in a contemporaneous series of patients undergoing either microscopic or endoscopic transsphenoidal surgery for nonfunctioning pituitary macroadenomas without imaging evidence of cavernous sinus invasion.

METHODS

This is a retrospective analysis of a prospectively collected database from a single institution. Data were collected from patients whose surgery had occurred in the period from June 2010 to January 2013. Patients who underwent microscopic or endoscopic surgery for Knosp Grade 0, 1, or 2 nonfunctioning pituitary macroadenomas were included in the study. Patients who had clinically secreting or Knosp Grade 3 or 4 tumors and patients who were undergoing revision surgery were excluded from analysis. Eligible patient records were analyzed for outcomes and complications. Statistical analyses were performed on tumor volume, intraoperative factors, postoperative complications, and degree of resection on 1-year postoperative MRI. The results were used to compare the outcomes after microscopic and endoscopic approaches.

RESULTS

Forty-three patients underwent microscopic transsphenoidal surgery, and 56 underwent endoscopic transsphenoidal surgery. There were no statistical differences in the intraoperative extent of resection or endocrinological complications. There were significantly more intraoperative CSF leaks in the endoscopic group (58% vs 16%); however, there was no difference in the incidence of postoperative CSF rhinorrhea (12% microscopic vs 7% endoscopic). Length of hospitalization was significantly shorter in patients undergoing an endoscopic approach (3.0 days vs 2.4 days). Two-month follow-up imaging was available in 95% of patients, and 75% of patients had 1-year follow-up imaging. At 2 months postprocedure, there was no evidence of residual tumor in 79% (31 of 39) and 85% (47 of 55) of patients in the microscopic and endoscopic groups, respectively. At 1 year postprocedure, 83% (25 of 30) of patients in the microscopic group had no evidence of residual tumor and 82% (36 of 44) of those in the endoscopic group had no evidence of residual tumor.

CONCLUSIONS

The microscopic and endoscopic techniques provide similar outcomes in the surgical treatment of Knosp Grades 0-2 nonfunctioning pituitary macroadenomas.

摘要

目的

本研究的目的是比较同期接受显微镜下或内镜下经蝶窦手术治疗无海绵窦侵袭影像学证据的无功能垂体大腺瘤患者的手术结果和并发症。

方法

这是一项对来自单一机构的前瞻性收集数据库的回顾性分析。数据收集自2010年6月至2013年1月期间接受手术的患者。纳入研究的患者为接受显微镜或内镜手术治疗Knosp 0级、1级或2级无功能垂体大腺瘤的患者。临床有分泌功能或Knosp 3级或4级肿瘤的患者以及接受翻修手术的患者被排除在分析之外。对符合条件的患者记录进行结局和并发症分析。对肿瘤体积、术中因素、术后并发症以及术后1年MRI的切除程度进行统计分析。结果用于比较显微镜下和内镜下手术方法后的结局。

结果

43例患者接受了显微镜下经蝶窦手术,56例接受了内镜下经蝶窦手术。术中切除范围或内分泌并发症方面无统计学差异。内镜组术中脑脊液漏明显更多(58%对16%);然而,术后脑脊液鼻漏的发生率无差异(显微镜下为12%,内镜下为7%)。接受内镜手术的患者住院时间明显更短(3.0天对2.4天)。95%的患者有术后2个月的影像学检查,75%的患者有术后1年的影像学检查。术后2个月时,显微镜组79%(39例中的31例)和内镜组85%(55例中的47例)的患者无残留肿瘤证据。术后1年时,显微镜组83%(30例中的25例)的患者无残留肿瘤证据,内镜组82%(44例中的36例)的患者无残留肿瘤证据。

结论

显微镜下和内镜下技术在治疗Knosp 0 - 2级无功能垂体大腺瘤的手术中提供相似的结果。

相似文献

1
Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.对单一机构中Knosp 0-2级无功能垂体大腺瘤的显微手术与内镜经蝶窦手术同期系列病例进行回顾性分析。
J Neurosurg. 2014 Sep;121(3):511-7. doi: 10.3171/2014.6.JNS131321. Epub 2014 Jul 4.
2
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
3
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.经验较少的外科医生采用完全内镜技术与经验非常丰富的外科医生采用显微镜下经蝶窦技术治疗垂体腺瘤的疗效比较。
J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16.
4
Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.功能性垂体腺瘤的全内镜经蝶窦手术:与同一机构传统经蝶窦显微手术的回顾性比较
Surg Neurol. 2009 Oct;72(4):336-40. doi: 10.1016/j.surneu.2009.04.012. Epub 2009 Jul 14.
5
Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.老年垂体腺瘤患者的鼻内镜经蝶窦手术
J Neurosurg. 2015 Jul;123(1):31-8. doi: 10.3171/2014.10.JNS14372. Epub 2015 Apr 3.
6
Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study.原发性与复发性经蝶窦切除术治疗无功能性垂体大腺瘤的对比:匹配队列研究。
J Neurosurg. 2017 Mar;126(3):889-896. doi: 10.3171/2016.3.JNS152735. Epub 2016 May 20.
7
Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach.巨大垂体腺瘤经鼻内镜手术 50 例的治疗效果分析。
World Neurosurg. 2014 Jul-Aug;82(1-2):e281-90. doi: 10.1016/j.wneu.2013.08.028. Epub 2013 Aug 29.
8
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal.内镜切除无功能垂体腺瘤后手术效果改善的证据。
Neurosurg Focus. 2011 Apr;30(4):E11. doi: 10.3171/2011.1.FOCUS10308.
9
Extent of Resection, Visual, and Endocrinologic Outcomes for Endoscopic Endonasal Surgery for Recurrent Pituitary Adenomas.复发性垂体腺瘤经鼻内镜手术的切除范围、视觉及内分泌学结果
World Neurosurg. 2017 Jun;102:35-41. doi: 10.1016/j.wneu.2017.02.131. Epub 2017 Mar 9.
10
Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.促甲状腺激素分泌型垂体腺瘤的临床病理特征及治疗结果:一项90例的单中心研究
J Neurosurg. 2014 Dec;121(6):1462-73. doi: 10.3171/2014.7.JNS1471. Epub 2014 Sep 19.

引用本文的文献

1
Endoscopic Transsphenoidal Sellar Surgery via One Nostril: Own Experience and Systematic Review of the Literature.经单鼻孔的内镜经蝶鞍手术:自身经验及文献系统综述
Life (Basel). 2025 Aug 4;15(8):1233. doi: 10.3390/life15081233.
2
Comparison of endoscopic and endoscope-assisted microscopic transsphenoidal surgery for pituitary adenoma resection: a prospective randomized study.内镜与内镜辅助显微镜下经蝶窦手术切除垂体腺瘤的比较:一项前瞻性随机研究。
Front Endocrinol (Lausanne). 2025 Jul 22;16:1552526. doi: 10.3389/fendo.2025.1552526. eCollection 2025.
3
Safety and efficacy of endoscopic vs. microscopic approaches in pituitary adenoma surgery: A systematic review and meta-analysis.
垂体腺瘤手术中内镜与显微镜入路的安全性和有效性:一项系统评价和荟萃分析。
Neurosurg Rev. 2025 Jun 1;48(1):471. doi: 10.1007/s10143-025-03600-3.
4
The Predictors of Postoperative Cerebrospinal Fluid Leak in Endoscopic Endonasal Pituitary Surgery: The Role of Tumor Volume.内镜下经鼻垂体手术术后脑脊液漏的预测因素:肿瘤体积的作用
J Neurol Surg B Skull Base. 2023 Apr 13;85(3):318-324. doi: 10.1055/a-2065-6377. eCollection 2024 Jun.
5
Predictive value of cyst/tumor volume ratio of pituitary adenoma for tumor cell proliferation.垂体腺瘤的囊/肿瘤体积比对肿瘤细胞增殖的预测价值。
BMC Med Imaging. 2024 Mar 21;24(1):69. doi: 10.1186/s12880-024-01246-z.
6
Safeness of sodium fluorescein administration in neurosurgery: Case-report of an erroneous very high-dose administration and review of the literature.荧光素钠在神经外科手术中的安全性:一例超高剂量误注病例报告及文献综述
Brain Spine. 2022 Dec 12;2:101703. doi: 10.1016/j.bas.2022.101703. eCollection 2022.
7
Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.垂体大腺瘤大小对其预后的影响:巨大腺瘤与非巨大腺瘤的比较分析。
J Neurooncol. 2022 Nov;160(2):491-496. doi: 10.1007/s11060-022-04168-4. Epub 2022 Oct 31.
8
Confocal laser imaging in neurosurgery: A comprehensive review of sodium fluorescein-based CONVIVO preclinical and clinical applications.神经外科中的共聚焦激光成像:基于荧光素钠的CONVIVO临床前和临床应用的全面综述。
Front Oncol. 2022 Oct 3;12:998384. doi: 10.3389/fonc.2022.998384. eCollection 2022.
9
AKU Giant Pituitary Adenoma Score: A Novel Scoring System to Predict the Outcomes of Surgery for Giant Pituitary Adenomas.AKU 巨大垂体腺瘤评分:一种预测巨大垂体腺瘤手术结局的新型评分系统。
Cureus. 2022 Sep 16;14(9):e29232. doi: 10.7759/cureus.29232. eCollection 2022 Sep.
10
Clinical application of the "sellar barrier's concept" for predicting intraoperative CSF leak in endoscopic endonasal surgery for pituitary adenomas with a machine learning analysis.“鞍膈屏障概念”在垂体腺瘤鼻内镜手术中预测术中脑脊液漏的临床应用及机器学习分析
Front Surg. 2022 Sep 8;9:934721. doi: 10.3389/fsurg.2022.934721. eCollection 2022.